| Literature DB >> 35745772 |
Valentina O Plastun1, Ekaterina S Prikhozhdenko1, Olga I Gusliakova1, Svetlana V Raikova2,3, Timothy E L Douglas4,5, Olga A Sindeeva6, Oksana A Mayorova1,7.
Abstract
Infectious sequelae caused by surgery are a significant problem in modern medicine due to their reduction of therapeutic effectiveness and the patients' quality of life.Recently, new methods of local antimicrobial prophylaxis of postoperative sequelae have been actively developed. They allow high local concentrations of drugs to be achieved, increasing the antibiotic therapy's effectiveness while reducing its side effects. We have developed and characterized antimicrobial hydrogels based on an inexpensive and biocompatible natural substance from the dairy industry-whey protein isolate-as matrices for drug delivery. The release of cefazolin from the pores of hydrogel structures directly depends on the amount of the loaded drug and occurs in a prolonged manner for three days. Simultaneously with the antibiotic release, hydrogel swelling and partial degradation occurs. The WPI hydrogels absorb solvent, doubling in size in three days and retaining cefazolin throughout the duration of the experiment. The antimicrobial activity of cefazolin-loaded WPI hydrogels against Staphylococcus aureus growth is prolonged in comparison to that of the free cefazolin. The overall cytotoxic effect of cefazolin-containing WPI hydrogels is lower than that of free antibiotics. Thus, our work shows that antimicrobial WPI hydrogels are suitable candidates for local antibiotic therapy of infectious surgical sequelae.Entities:
Keywords: antimicrobial activity; cefazolin; drug release; hydrogel; whey protein isolate
Year: 2022 PMID: 35745772 PMCID: PMC9231275 DOI: 10.3390/pharmaceutics14061199
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.525
Figure 1(a) The principal scheme for the formation of WPI-based hydrogels containing cefazolin. Control WPI hydrogels were prepared similarly without the addition of antibiotics. (b) The cefazolin cumulative release profile from WPI hydrogel disks incubated in saline at 37 °C for 144 h. Error bars show cumulative standard deviations calculated from five measurements for a sample in each treatment stage. (c) Mass increase (swelling profile) of WPI hydrogels containing cefazolin incubated in saline at 37 °C. Error bars show standard deviation, calculated from five measurements for a sample in each treatment stage. (d) Morphological analysis of WPI hydrogels with cefazolin. The scale bar for SEM images of transverse-sections is 5 m.
Figure 2(a) The principal scheme of the experiment to study the antibacterial activity of WPI-based hydrogels with different cefazolin concentrations on dense nutrient media against S. aureus. (b) Average growth inhibition zone sizes and (c) visualization of S. aureus bacterial strains during study of an antimicrobial action of WPI-based hydrogels containing cefazolin, cefazolin standard disk (control), WPI-hydrogel (0 mg/mL of cefazolin) by agar diffusion method. Values are presented as means ± standard deviations (n = 5).
Figure 3(a) The principal experiment scheme to study the antibacterial activity of WPI-based hydrogels with cefazolin in liquid media. (b) Total number of bacteria in nutrient broth compared with control (c) live–dead analysis of experimental bacterial suspension by flow cytometry. (d) CLSM images of bacterial suspensions after incubation with cefazolin-containing hydrogel samples. Green color indicates live bacteria (Syto 9), red color indicates dead ones (PI). The scale bar in all images is 50 m.
Figure 4(a) CLSM images of L929 incubated with free and immobilized cefazolin (0, 0.5, 5, 10 mg/mL) for 48 h. For immobilized cefazolin, gel-free areas and areas under gel are specified. Blue color indicates nuclei (DAPI), and red indicates lipid components on membrane and inside the cell (Nile red). Images inserted to the left upper corner are brightfield images. Scale bars are 50 m. (b) Viability of the L929 cell line incubated with free and immobilized in WPI disks cefazolin (0, 0.5, 5, 10 mg/mL) for 48 h.